Esai and Biogen, Lequembi manufacturer, receive FDA approval for Alzheimer's drug. Eisai and Biogen's drug, sold under the brand name Leqembi, is the first amyloid-targeting medication to pass the FDA's full review. Source 8o.
Sponsored Links:
Post Date:Thu Apr 3 16:50:34 GMT 2025 / Post ID: #
Comment
Lecanemab
I feel lecanemab is interesting quickly to understand lecanemab carefully to get the facts.
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,
Add Reply
Add Comment As A Guest
Close Topic Options